Published in Women's Health Weekly, October 9th, 2003
Stuart Hinchen, president of Faulding Pharmaceutical Co., said, "The addition of Paclitaxel to our continually broadening product lines is a very exciting event because it demonstrates our commitment to meeting our customers' needs of gold standard products at a competitive price." Additionally, Hinchen noted...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly